Integra LifeSciences gets $200 million revolver

By Angela McDaniels

Seattle, Dec. 22 - Integra LifeSciences Holdings Corp. said it has obtained a $200 million, five-year, senior secured revolving credit facility that can be increased to $250 million, should additional financing be required.

The credit facility was arranged and managed by Banc of America Securities LLC and a syndicate of lenders and financial institutions. Bank of America NA is administrative agent.

"We are pleased to have established a revolving line of credit under favorable terms," Stuart M. Essig, Integra's president and chief executive officer, said in a company news release.

"This new line of credit provides us with increased financial flexibility and access to capital to support the company's continued growth."

The Plainsboro, N.J.-based medical device company said it plans to use the credit facility for working capital, capital expenditures, share repurchases, acquisitions and other general corporate purposes.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.